Regencell Bioscience Holdings Ltd financial data

Symbol
RGC on Nasdaq
Location
11/F First Commercial Building, 33 35 Leighton Road, Causeway Bay, Hong Kong, Hong Kong
State of incorporation
Cayman Islands
Latest financial report
20-F - Q2 2024 - Oct 25, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 13M shares 0%
Common Stock, Shares, Outstanding 13M shares 0%
Common Stock, Value, Issued 130 USD 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.42M USD +10701%
Assets, Current 8.11M USD -30.2%
Property, Plant and Equipment, Net 142K USD -67.8%
Operating Lease, Right-of-Use Asset 84.8K USD -81.2%
Assets 8.44M USD -33.1%
Accrued Liabilities, Current 125K USD -20.7%
Liabilities, Current 194K USD -68.1%
Operating Lease, Liability, Noncurrent 25.9K USD +2.08%
Liabilities 220K USD -65.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -45.8K USD +47.2%
Retained Earnings (Accumulated Deficit) -21.6M USD -24.8%
Stockholders' Equity Attributable to Parent 8.22M USD -31.7%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 8.22M USD -31.5%
Liabilities and Equity 8.44M USD -33.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 13M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.96M USD +89.2%
Deferred Tax Assets, Valuation Allowance 3.47M USD +19.1%
Operating Lease, Liability 85.7K USD -81.5%
Lessee, Operating Lease, Liability, to be Paid 87.9K USD
Property, Plant and Equipment, Gross 926K USD +0.97%
Operating Lease, Liability, Current 59.8K USD -86.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 25.1K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 62.8K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.18K USD
Deferred Tax Assets, Operating Loss Carryforwards 2.79M USD +20.9%
Additional Paid in Capital 28.5M USD +11136347%